Skip to content

The Minnesota Manual Dexterity Test As A Measure Of Hand Function in Multiple Sclerosis

Upper Limb Assessment in Multiple Sclerosis: The Minnesota Manual Dexterity Test As A Measure Of Hand Function

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04721340
Enrollment
80
Registered
2021-01-22
Start date
2021-02-02
Completion date
2021-05-16
Last updated
2021-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

multiple sclerosis, upper limb, manual dexterity, assessment, minnesota manual dexterity test

Brief summary

The aim of the study is to report the results of manual dexterity using the Minnesota Manual Dexterity Test in people with Multiple Sclerosis.

Detailed description

Upper limb can be affected even in early stage in people with Multiple Sclerosis (pwMS). Manual dexterity is important to maintain upper limb function and 9-Hole Peg Test (9HPT) is used as gold standard to assess dexterity in pwMS. There are no studies evaluating manual dexterity with the Minnesota Manual Dexterity Test (MMDT) in pwMS. This study aims to: 1. reporting the results of manual dexterity using the Minnesota Manual Dexterity Test and comparing the test results with healthy volunteers, 2. examining the relationship between MMDT and 9HPT, ABILHAND, grip strength, pinch strength, fatigue.

Interventions

Individuals who meet the inclusion criteria will be evaluated for manual dexterity, performance, muscle strength and fatigue, respectively, on a predetermined day.

Individuals who meet the inclusion criteria will be evaluated for manual dexterity, performance, muscle strength and fatigue, respectively, on a predetermined day.

Sponsors

Istanbul Aydın University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* (1) age 18-65; * (2) definitive diagnosis of MS according to McDonald criteria; * (3) ability to read and write in Turkish.

Exclusion criteria

* (1) acute attacks of MS (within 3 months); * (2) cognitive impairment (Mini Mental test result 24 points and below); * (3) having spasticity (3 and above according to Modified Ashworth Scale) * (4) any chronic disease other than MS; * (5) being addicted to alcohol or drugs,

Design outcomes

Primary

MeasureTime frameDescription
Minnesota Manual Dexterity Testbaseline (on the predetermined assessment day)to assess manual dexterity, higher scores mean a worse outcome.

Secondary

MeasureTime frameDescription
9-Hole Peg Testbaseline (on the predetermined assessment day)to assess manual dexterity. higher scores mean a worse outcome.
ABILHANDbaseline (on the predetermined assessment day)to assess for performance of activity. score range 0-46 point, higher scores mean a better outcome.
grip strengthbaseline (on the predetermined assessment day)using hand dynamometer. higher scores mean a better outcome.
pinch strengthbaseline (on the predetermined assessment day)using pinchmeter. higher scores mean a better outcome.
Fatigue Severity Scalebaseline (on the predetermined assessment day)to assess fatigue. score range 0-7 point, higher scores mean a worse outcome.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026